NCT05723510View on ClinicalTrials.gov

PK and PD Interaction Between Tegoprazan and NOACs After Multiple Oral Dosing in Healthy Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

87

Participants

Timeline

Start Date

March 6, 2023

Primary Completion Date

July 17, 2023

Study Completion Date

July 24, 2023

Conditions
Healthy
Interventions
DRUG

Tegoprazan 50mg

Oral administration of one tablet of tegoprazan 50 mg once daily

DRUG

Edoxaban 60mg

Oral administration of one tablet of edoxaban 60 mg once daily

DRUG

Apixaban 5mg

Oral administration of one tablet of apixaban 5 mg twice daily

DRUG

Rivaroxaban 20mg

Oral administration of one tablet of rivaroxaban 20 mg once daily

Trial Locations (1)

Unknown

Jeonbuk National University Hospital, Jeonju

Sponsors
All Listed Sponsors
lead

HK inno.N Corporation

INDUSTRY